baber/WOPTO huggingface dataset:
Patent WO-2021133431-A1 (WO)
Inventor: BOSS JAKOB
IPC: B25B23/10
Filed: 2020-05-11
Abstract: A single-sided fastener retaining device includes a resilient arm and a lever arm joined by a fulcrum. A fork at the end of the lever arm includes first and second arms that extend to either side of and at least to the level of the axis of the driving tool to define an opening facing the axis to receive the shaft of a fastener of various sizes and hold the head of the fastener to the working end of the driving tool in a retained position. The release mechanism is responsive to the application of a force to elastically deform the resilient arm causing the lever arm to pivot on the fulcrum moving the fork away from the axis to a release position to release the fastener.
Patent WO-2020227722-A1 (WO)
Inventor: SKAKOON JAMES G
IPC: A61M35/00
Filed: 2020-05-11
Abstract: A topical applicator of the propel/repel type includes an expandable reservoir with a port, an attachable applicator tip, and a metered dosing system. The reservoir can be a cylindrical housing with a movable elevator movable by a drive mechanism that is initially not engaged to allow filling of a flowable compound through the port, moving the elevator. An actuator, such as a rotating ring or pushbutton may engage the drive mechanism. The drive mechanism can include a one-way ratcheting feature. Metered doses can be dispensed through a hole or holes in the applicator tip by rotating a dosing knob or pushing a pushbutton causing the drive mechanism to advance the elevator. The drive mechanism and the action to dispense metered doses can be combined into a single motion. The drive mechanism can include detent positions that correspond to discrete doses, and can also provide audible and tactile feedback.
Patent WO-2020256897-A1 (WO)
Inventor: MURDOCH BRANDON
IPC: G06F21/64
Filed: 2020-05-26
Abstract: Use of a validation data structure in order to securely communicate an encrypted claim that has a decentralized identifier as a subject. The sending system generates the validation data structure and presents the validation data structure to a user that owns the decentralized identifier. The sending system encrypts the claim using at least the validation data structure, and constructs a message that includes the encrypted claim, but which does not include the validation data structure. The relying party receives the message. However, without separately receiving the validation data structure from the user, the relying party computing system cannot decrypt the encrypted claim. If the user wishes the relying party computing system to have access to the claim, the user may communicate the validation data structure to the relying party computing system.
Patent WO-2020247770-A1 (WO)
Title: Continuous-flow, well mixed, microfluidic crystallization device for screening polymorphs, morphologies and crystallization kinetics at controlled supersaturation
Inventor: SINGH MEENESH R
IPC: B01L3/00
Filed: 2020-06-05
Abstract: The disclosure relates to a microfluidic system for the screening of polymorphs, morphology, and crystallization kinetics under well-mixed, continuous-flow at controlled supersaturations. The disclosure also relates to a method for screening crystalline polymorphs and morphology, and crystallization kinetics. The microfluidic system includes a microfluidic chamber having one or more inlets, a passive mixing zone, and a trap zone. The passive mixing zone promotes mixing of solvent, solute, and optionally antisolvent under stable, controlled levels of supersaturation. The trap zone similarly has stable, controlled levels of supersaturation and correspondingly low velocity to retain solute crystals formed in the trap zone for time-dependent evaluation.
Patent WO-2020257378-A1 (WO)
Title: Fluides de transfert de chaleur et procédés d'utilisation
Inventor: CHRISTENSEN GARY
IPC: C09K5/10
Filed: 2020-06-18
Abstract: La présente invention concerne des fluides de transfert de chaleur destinés à être utilisés dans des systèmes de transfert de chaleur. Les fluides de transfert de chaleur comprennent au moins un fluide de transfert de chaleur diélectrique non aqueux. Le fluide de transfert de chaleur diélectrique non aqueux a des propriétés de conductivité thermique (k) et de densité (ρ). Les fluides de transfert de chaleur ont un facteur d'efficacité normalisé (NEFfluid) tel que déterminé par l'équation suivante : (équation) DEFfluid étant un facteur d'efficacité dimensionnelle pour le fluide de transfert de chaleur qui est déterminé sur la base d'une équation désignée dans le tableau 1 ci-dessous pour une pompe sélectionnée, un régime d'écoulement dominant de circuit de transfert de chaleur qui est un écoulement turbulent, et un régime d'écoulement dominant d'appareil qui est un écoulement laminaire ; DEFreference étant un facteur d'efficacité dimensionnelle pour un fluide de référence qui est déterminé à l'aide de la même équation désignée dans le tableau 1 pour DEFfluid ci-dessus pour la même pompe sélectionnée, le même régime d'écoulement dominant de circuit de transfert de chaleur qui est un écoulement turbulent, et le même régime d'écoulement dominant d'appareil qui est un écoulement laminaire ; et (tableau1) le fluide de transfert de chaleur ayant une valeur NEFfluid supérieure ou égale à 1,0. La présente invention concerne également un procédé d'amélioration des performances d'un système de transfert de chaleur, un procédé d'amélioration de la performance d'un appareil, et un procédé de sélection d'un fluide de transfert de chaleur destiné à être utilisé dans un système de transfert de chaleur. Les fluides de transfert de chaleur et les procédés de la présente invention sont applicables dans des situations où le système de transfert de chaleur est dominé par un transfert de chaleur localisé.
Patent WO-2020257783-A1 (WO)
Inventor: ARAVAMUDAN MURALI
IPC: H04L29/06
Filed: 2020-06-22
Abstract: Techniques are provided for computing with private healthcare data. The techniques include a method comprising constructing an isolated memory partition that forms a secure enclave and pre-provisioning software within the secure enclave. The pre-provisioned software is configured to receive at least one of input data or the instructions for the one or more application computing processes in an encrypted form; decrypt the at least one of input data or instructions using one or more cryptographic keys; execute the one or more application computing processes based on the decrypted at least one of input data or instructions to generate output data; generate a proof of execution that indicates that the one or more application computing processes operated on the received input data; encrypt the output data using the one or more cryptographic keys; and provide external access to the encrypted output data and the proof of execution.
Patent WO-2021030050-A1 (WO)
Inventor: Khaleghimeybodi Morteza
IPC: H04R1/10
Filed: 2020-07-28
Abstract: An ear-plug assembly presents audio content to an ear canal of a user. The audio content may be based in part on sound in a local area surrounding the user. The ear-plug assembly detects, via one or more acoustic sensors, sound in the area around the user. The sound waves travel through an aperture in a body of the ear-plug assembly and are propagated to a waveguide to the one or more acoustic sensors. The ear-plug assembly processes the detected sound data in a controller, which instructs a speaker assembly to present audio content based in part on the detected sound data. The detected sounds may be amplified, attenuated, filtered, and/or augmented when presented by the speaker assembly.
Patent WO-2021030114-A1 (WO)
Inventor: ABEDINI NAVID
IPC: H04W74/04
Filed: 2020-08-05
Abstract: Aspects relate to a physical cell identifier (PCI) change within a wireless network based on a primary synchronization signal (PSS) waveform. A scheduling entity, such as an integrated-access-backhaul (IAB) node within a radio access network (RAN), may communicate with a set of one or more scheduled entities, such as other IAB nodes and/or user equipment (UEs), utilizing a first PCI. The scheduling entity may then change from the first PCI to a second PCI, where the second PCI corresponds to a different PSS waveform than the first PCI. In some examples, the scheduling entity may change the PCI as a result of a PCI collision and/or PSS collision with a neighboring scheduling entity.
Patent WO-2021041762-A1 (WO)
Inventor: HSU AN
IPC: C12Q1/68
Filed: 2020-08-28
Abstract: Provided is a kit for detecting epidermal growth factor receptor variant III (EGFRvIII). The kit includes an EGFRvIII fusion-specific primer pair and an EGFRvIII fusion-specific probe with high specificity. Also provided is a method for detecting EGFRvIII, including generating an amplified target cDNA to hybridize with the EGFRvIII fusion-specific probe and detecting the probe-bound product to identify EGFRvIII in a biological sample.
Patent WO-2021042015-A1 (WO)
Title: Biodegradable soft elastomers for regenerative engineering
Inventor: AMEER GUILLERMO A
IPC: C12N5/077
Filed: 2020-08-31
Abstract: Provided herein are materials and methods related to scaffolds and uses thereof. In some embodiments, provided herein are poly (octamethylene-octanol citrates) (POOC) scaffolds with native mechanical properties that are comparable to urinary bladder tissue. In some embodiments, provided herein are methods for the synthesis of POOC scaffolds with native mechanical properties that are comparable to urinary bladder tissue by including octanol in the polycondensation synthesis of POC. In some embodiments, provided herein are methods of use of the disclosed scaffolds, including for urinary bladder tissue regeneration.
Patent WO-2022086502-A1 (WO)
Title: Arb disconnect system with improved roll gradient and understeer characteristics
Inventor: OTTEN ERIK
IPC: B60G17/02
Filed: 2020-10-20
Abstract: A suspension assembly for a vehicle suspension system may include a lower control arm, an upper control arm, a damper, and a drop link. The lower control arm may be operably coupled to a chassis of a vehicle via a first bushing assembly and a second bushing assembly. The first and second bushing assemblies may each pivot about an axis substantially parallel to a longitudinal centerline of the vehicle. The upper control arm may be operably coupled to the chassis. The damper may be operably coupled to the lower control arm to dampen pivoting motion of the upper and lower control arms relative to the chassis. The drop link may operably couple the lower control arm and an anti-roll bar that includes a disconnect assembly to translate a roll motion into a force exerted on the lower control arm in a direction substantially parallel to the axis.
Patent WO-2021081496-A1 (WO)
Title: Delta e formula match prediction
Inventor: WILLIS ROBERT
IPC: G06K9/46
Filed: 2020-10-26
Abstract: A method of determining a color formulation for a target color begins with generating a plurality of candidate color formulations to reproduce the target color. For each candidate formulation, a predicted delta E indicating a difference from a predicted color for the candidate formulation from the target color is determined. Also for each candidate formulation, a confidence value in the predicted delta E is generated by summing weighted figures of merit for each colorant in the candidate formulation. The weighting of the figures of merit represents each colorants proportion in the candidate formulation. A formulation is then selected based on the predicted delta E and confidence value. The target color may be defined in terms of a multidimensional color space.
Patent WO-2021092427-A1 (WO)
Inventor: CANTWELL MARK
IPC: A61K35/761
Filed: 2020-11-06
Abstract: L'invention concerne des adénovirus oncolytiques à réplication améliorée. Ces adénovirus oncolytiques ont une réplication spécifique de tumeurs capable d'une oncolyse tumorale améliorée et d'une expression améliorée de transgènes thérapeutiques. L'invention concerne également des procédés comprenant l'administration d'un adénovirus oncolytique à réplication améliorée pour des patients souffrant d'un cancer.
Patent WO-2021101762-A1 (WO)
Inventor: DOWNIE MARK ANTHONY JELF
IPC: G06F11/36
Filed: 2020-11-11
Abstract: Embodiments provide improved diagnosis of software defects. Static analysis services and other source-based diagnostic tools and techniques are applied even when the source code underlying software is unavailable. Diagnosis obtains diagnostic artifacts, extracts diagnostic context from the artifacts, decompiles to get source, and submits decompiled source to a source-based software analysis service. The analysis service may be a static analysis tool, an antipattern scanner, or a machine learning model trained on source code, for example. The diagnostic context may also guide the analysis, e.g., by localizing decompilation or prioritizing possible causes. Likely causes are culled from analysis results and identified to a software developer. Changes to mitigate the defect's impact are suggested. Thus, the software developer receives debugging leads without providing source code for the defective program, and without manually navigating through a decompiler and through the analysis services.
Patent WO-2021097074-A1 (WO)
Title: Intestinal organoid co-culture systems and methods for treating or preventing a disease or disorder associated with immune response-mediated tissue injury
Inventor: CADWELL KEN
IPC: C12N5/071
Filed: 2020-11-12
Abstract: The invention provides methods for administering necroptosis or interferon signaling inhibitors for treating or preventing immune-related tissue injury in a subject having an inactivating mutation in ATG16L1. The invention also provides organoid cultures and co-cultures and methods of use for identifying therapeutic agents. In some embodiments, the invention relates to methods of treating or preventing a disease or disorder associated with immune response-mediated tissue injury in a subject in need thereof, the method comprising: identifying the subject as having an inactivating mutation in the Autophagy Related 16 Like 1 gene (ATG16L 1), and administering to the subject at least one of an inhibitor of necroptosis and an inhibitor of interferon signaling.
Patent WO-2021097111-A1 (WO)
Title: Improved logistical management system
Inventor: RUSNAK RYAN
IPC: G06Q30/00
Filed: 2020-11-12
Abstract: Disclosed herein are system, method, and computer program product embodiments for selecting a particular eligible transporter for transporting a first good for a first job. An embodiment operates by receiving a request for transporting the good from a pickup location to a delivery location. Thereafter, eligible transporters for transporting the good from the pickup location to a first intermediate location or the delivery location (option one), or from the first intermediate location to a second intermediate location or the delivery location (option two), are identifier. Subsequently, for each eligible transporter, an estimated completion time (ECT) for the transporting of the first good is derived. Based on the ECT for each eligible transporter, a request to transport the good is sent to one of the eligible transporters.
Patent WO-2021101820-A1 (WO)
Inventor: GREPALY ISTVAN
IPC: F16L57/06
Filed: 2020-11-16
Abstract: A rubber hose includes a distinctly colored inner wear indicator integrated into its liner, wherein a distance  b  of the inner wear indicator from the inner surface of the liner is less than 40% of the liner's thickness  v , and height  h  of the wear indicator, measured perpendicularly to a longitudinal axis of the hose, falls between 1% to 90% of liner thickness  v , or even from 10% to 40% of the liner thickness  v . The inner wear indicator may have concentric sectional surface area of the inner wear indicator may even gradually decrease in the radial direction as a function of distance from the longitudinal axis. The rubber hose may be connected at one end to a plunger pump and connected at a second to a common manifold, in an oilfield pump system, or used in any hose application in an oilfield fluid pump system.
Patent WO-2021102002-A1 (WO)
Inventor: SARKIS GABI
IPC: H04W76/14
Filed: 2020-11-18
Abstract: Aspects directed towards reserving resources for sidelink communications are disclosed. In one example, an initial sidelink communication is transmitted which includes an indication of resources reserved for a subsequent sidelink communication. A transmission restriction is applied for the subsequent sidelink communication based on a transmission characteristic associated with transmitting the initial sidelink communication. The subsequent sidelink communication is then transmitted according to the transmission restriction.
Patent WO-2021108210-A1 (WO)
Title: Système de distribution d'agent bénéfique comprenant des microcellules ayant une couche d'étanchéité à électro-érosion
Inventor: LIU LEI
IPC: A61F13/00
Filed: 2020-11-19
Abstract: La présente invention concerne un système de distribution d'agent bénéfique qui permet de distribuer des agents bénéfiques à la demande et/ou de distribuer divers agents bénéfiques différents à différentes concentrations à partir du même système. Le système de distribution d'agent bénéfique comprend une couche de microcellules comprenant une pluralité de microcellules, les microcellules étant remplies d'un support et d'un agent bénéfique. Les microcellules comprennent une ouverture, l'ouverture étant couverte par une couche d'étanchéité comprenant un polymère et un matériau métallique. L'application d'un champ électrique sur l'ensemble de la couche de microcellules et de la couche d'étanchéité entraîne la migration du matériau métallique à partir de la couche d'étanchéité et la création d'une couche d'étanchéité poreuse, ce qui permet à l'agent bénéfique d'être libéré du système de distribution d'agent bénéfique.
Patent WO-2021108483-A1 (WO)
Title: Composés thérapeutiques
Inventor: CRAWFORD JAMES JOHN
IPC: C07D487/04
Filed: 2020-11-25
Abstract: La présente invention concerne des composés de formule (I) : (I) et des sels pharmaceutiquement acceptables de ceux-ci, ainsi que des compositions et leurs utilisations. Les composés sont utiles en tant qu'inhibiteurs de l'interaction protéine : protéine YAP : TEAD. L'invention concerne également des compositions pharmaceutiques comprenant un composé de formule (I) ou un sel pharmaceutiquement acceptable de celui-ci, et des procédés d'utilisation de tels composés et sels dans le traitement de divers troubles médiés par YAP : TEAD, notamment du cancer.
Patent WO-2021154377-A1 (WO)
Title: System and techniques for secret key transfer in benefit denial system
Inventor: SHEFFIELD MASON E
IPC: H04W12/06
Filed: 2020-11-25
Abstract: Techniques described herein are directed to a system and methods for issuing commands to an electronic device as well as techniques for transferring a device key to a user device associated with a user who has gained authorization to issue commands to the electronic device. In some embodiments, a device key may be conveyed directly from an access device to a user device. In some embodiments, the device key may be conveyed to a user device by a mobile application server which is in communication with the user device upon receiving an indication that an operator of the user device is authorized to issue commands to the electronic device.
Patent WO-2021138462-A1 (WO)
Title: Segmented fluid end plunger pump
Inventor: HINDERLITER BRANDON
IPC: F04B47/02
Filed: 2020-12-30
Abstract: A fluid end for a fracturing pump includes a plurality of segments (202, 204, 206) coupled together along a discharge axis (208), each segment of the plurality of segments (202, 204, 206) having a plurality of suction bores (212). The fluid end also includes respective interfaces between segment pairs formed by adjacent segments of the plurality of segments, the interfaces coupling the segment pairs together. The fluid end further includes respective access areas (210) proximate the respective interfaces, the respective access areas (210) configured to provide access for mechanical couplings to join the segment pairs together.
Patent WO-2020252506-A1 (WO)
Title: Extraction de substance présente dans des lumières corporelles
Inventor: NGUYEN HOAI
IPC: A61B18/14
Filed: 2020-06-11
Abstract: L'extraction d'une substance présente dans des lumières vasculaires peut être améliorée par utilisation d'un élément distal comprenant une maille expansible, un dispositif de traitement comprenant un élément allongé ayant une partie proximale et une partie distale conçu pour être positionné à l'intérieur d'un vaisseau sanguin au niveau d'un site de traitement au niveau ou à proximité d'un thrombus. Un élément distal comprenant une maille expansible est accouplé à la partie distale de l'élément allongé par l'intermédiaire d'un ensemble de raccordement. Dans un état expansé, au moins une partie de la maille est conçue pour être en apposition avec la paroi de vaisseau sanguin au niveau du site de traitement pour ancrer ou stabiliser l'élément allongé par rapport au vaisseau sanguin. L'élément distal peut être couplé électriquement à un générateur de courant extracorporel.
Patent WO-2021119662-A1 (WO)
Inventor: AL MAJID NEWAR HUSAM
IPC: H04N21/4788
Filed: 2020-12-09
Abstract: Systems and methods are provided for performing operations including: receiving, by a messaging application, input that selects an option to generate a message using an avatar with a caption; presenting, by the messaging application, the avatar and a caption entry region proximate to the avatar; populating, by the messaging application, the caption entry region with a text string comprising one or more words; determining, by the messaging application, context based on the one or more words in the text string; and modifying, by the messaging application, an expression of the avatar based on the determined context.
Patent WO-2021138654-A1 (WO)
Inventor: HUA GANG
IPC: G06T7/50
Filed: 2021-01-04
Abstract: L'invention concerne un procédé de traitement d'erreur dans un moteur de correction géométrique (GCE) qui comprend la réception (800) de paramètres de configuration par le GCE, la génération (802), par le GCE en fonction des paramètres de configuration, de blocs de sortie d'une trame de sortie sur la base de blocs correspondants d'une trame d'entrée, la détection (804), par le GCE, d'une erreur d'exécution pendant la génération, et le signalement (806), par le GCE, d'un événement correspondant à l'erreur d'exécution.
Patent WO-2021188196-A1 (WO)
Title: Causality determination of upgrade regressions via comparisons of telemetry data
Inventor: NICOLAE ANDREI
IPC: H04L12/24
Filed: 2021-01-21
Abstract: Disclosed herein is a system for automating the causality detection process when upgrades are deployed to different resources that provide a service. The resources can include physical and/or virtual resources (e.g., processing, storage, and/or networking resources) that are divided into different, geographically dispersed, resource units. To determine whether a root cause of a problem is associated with an upgrade event that has recently been deployed, a system is configured to use telemetry data to compute an upgrade-to-upgrade score that represents differences between two different upgrade events that are deployed to the same resource unit. The system is further configured to use telemetry data to compute an upgrade unit-to-unit score that represents differences between the same upgrade event being deployed to two different resource units. The scores can be used to output an alert, for an analyst, that signals whether a recently deployed upgrade event is the cause of a problem.